| Medico Remedies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540937 |
NSE Symbol : MEDICO |
P/E(TTM) : 21.09 |
|
ISIN Demat : INE630Y01024 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.66 |
|
Book Value(₹) : 9.10 |
Market Cap(₹Cr) : 290.53 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 69.40 | 56.81 | 58.68 | 52.64 | 38.25 | 41.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 69.40 | 56.81 | 58.68 | 52.64 | 38.25 | 41.30 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.17 | 2.87 | 0.68 | 1.72 | 0.66 | 0.29 |
| Total Income | 70.57 | 59.68 | 59.36 | 54.36 | 38.91 | 41.60 |
| Total Expenditure | 66.10 | 49.66 | 54.35 | 49.92 | 35.43 | 34.64 |
| PBIDT | 4.47 | 10.02 | 5.01 | 4.44 | 3.48 | 6.96 |
| Interest | 0.41 | 0.90 | 0.39 | 0.24 | 0.28 | 0.49 |
| PBDT | 4.06 | 9.12 | 4.62 | 4.21 | 3.20 | 6.46 |
| Depreciation | 0.72 | 0.80 | 0.79 | 0.73 | 0.77 | 0.77 |
| Tax | 0.71 | 2.89 | 0.86 | 0.77 | 0.54 | 1.88 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.11 | -0.42 | 0.10 | 0.13 | 0.08 | -0.52 |
| Reported Profit After Tax | 2.52 | 5.86 | 2.87 | 2.57 | 1.82 | 4.34 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.52 | 5.86 | 2.87 | 2.57 | 1.82 | 4.34 |
| EPS (Unit Curr.) | 0.30 | 0.71 | 0.35 | 0.31 | 0.22 | 0.52 |
| EPS (Adj) (Unit Curr.) | 0.30 | 0.71 | 0.35 | 0.31 | 0.22 | 0.52 |
| Calculated EPS (Unit Curr.) | 0.30 | 0.71 | 0.35 | 0.31 | 0.22 | 0.52 |
| Calculated EPS (Adj) (Unit Curr.) | 0.30 | 0.71 | 0.35 | 0.31 | 0.22 | 0.52 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.21 | 2.82 | 1.38 | 1.24 | 0.88 | 2.09 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.21 | 2.82 | 1.38 | 1.24 | 0.88 | 2.09 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 | 16.60 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 6.44 | 17.64 | 8.54 | 8.43 | 9.10 | 16.85 |
| PBDTM(%) | 5.85 | 16.05 | 7.87 | 8.00 | 8.37 | 15.64 |
| PATM(%) | 3.63 | 10.32 | 4.89 | 4.88 | 4.76 | 10.51 |
